Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TREPROSTINIL Cause Increased bronchial secretion? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Increased bronchial secretion have been filed in association with TREPROSTINIL (TYVASO). This represents 0.0% of all adverse event reports for TREPROSTINIL.

8
Reports of Increased bronchial secretion with TREPROSTINIL
0.0%
of all TREPROSTINIL reports
0
Deaths
7
Hospitalizations

How Dangerous Is Increased bronchial secretion From TREPROSTINIL?

Of the 8 reports, 7 (87.5%) required hospitalization, and 1 (12.5%) were considered life-threatening.

Is Increased bronchial secretion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does TREPROSTINIL Cause?

Dyspnoea (16,348) Headache (14,051) Diarrhoea (11,335) Nausea (10,320) Cough (8,945) Fatigue (7,440) Dizziness (7,405) Infusion site pain (5,169) Vomiting (5,097) Death (4,764)

What Other Drugs Cause Increased bronchial secretion?

ALBUTEROL (637) OMALIZUMAB (144) MEPOLIZUMAB (119) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (93) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (87) FLUTICASONE\SALMETEROL (86) FLUTICASONE (82) PREDNISONE (74) TIOTROPIUM (65) BUDESONIDE\FORMOTEROL (63)

Which TREPROSTINIL Alternatives Have Lower Increased bronchial secretion Risk?

TREPROSTINIL vs TREPROSTINIL DIOLAMINE TREPROSTINIL vs TRETINOIN TREPROSTINIL vs TRIAMCINOLONE TREPROSTINIL vs TRIAMCINOLONE ACETONIDE TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE

Related Pages

TREPROSTINIL Full Profile All Increased bronchial secretion Reports All Drugs Causing Increased bronchial secretion TREPROSTINIL Demographics